Muller Lorenz, Chief Commercial Officer of Milestone Pharmaceuticals Inc. ($MIST), made two open market sales of company shares over the past year, totaling about $146,000. His latest sale occurred on January 26, 2026. These transactions rank 9,027th among 11,678 insiders in our database by sale value, well below the average of $8.6 million per person across roughly 6.4 trades. Lorenz recorded no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 2, 2026 | Milestone Pharmaceuticals Inc. | $MIST | Muller Lorenz | Chief Commercial Officer | A | Employee Stock Option (right to buy) | 204000 | $0.00 | 204,000.0000 | 85,169,344 | 9999.99% | 0.24% |
| Feb. 2, 2026 | Milestone Pharmaceuticals Inc. | $MIST | Muller Lorenz | Chief Commercial Officer | A | Restricted Stock Unit | 136000 | $0.00 | 136,000.0000 | 85,169,344 | 9999.99% | 0.16% |
| Feb. 2, 2026 | Milestone Pharmaceuticals Inc. | $MIST | Muller Lorenz | Chief Commercial Officer | A | Employee Stock Option (right to buy) | 204000 | $0.00 | 204,000.0000 | 85,169,344 | 9999.99% | 0.24% |
| Dec. 15, 2025 | Milestone Pharmaceuticals Inc. | $MIST | Muller Lorenz | Chief Commercial Officer | S | Common Shares | 53566 | $2.32 | 196,486.0000 | 85,169,344 | 21.42% | 0.06% |
| Dec. 12, 2025 | Milestone Pharmaceuticals Inc. | $MIST | Muller Lorenz | Chief Commercial Officer | A | Common Shares | 100000 | $0.00 | 250,052.0000 | 85,169,344 | 66.64% | 0.12% |
| Jan. 26, 2026 | Milestone Pharmaceuticals Inc. | $MIST | Muller Lorenz | Chief Commercial Officer | M | Common Shares | 20100 | $0.00 | 216,586.0000 | 85,169,344 | 10.23% | 0.02% |
| Jan. 26, 2026 | Milestone Pharmaceuticals Inc. | $MIST | Muller Lorenz | Chief Commercial Officer | S | Common Shares | 11180 | $1.93 | 205,406.0000 | 85,169,344 | 5.16% | 0.01% |
| Dec. 12, 2025 | Milestone Pharmaceuticals Inc. | $MIST | Muller Lorenz | Chief Commercial Officer | A | Employee Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 85,169,344 | 9999.99% | 0.12% |
| Jan. 26, 2026 | Milestone Pharmaceuticals Inc. | $MIST | Muller Lorenz | Chief Commercial Officer | M | Restricted Stock Units | 20100 | $0.00 | 60,300.0000 | 85,169,344 | 25.00% | 0.02% |
| Dec. 9, 2025 | Milestone Pharmaceuticals Inc. | $MIST | Muller Lorenz | Chief Commercial Officer | G | Common Shares | 25000 | $0.00 | 150,052.0000 | 85,169,344 | 14.28% | 0.03% |
| July 11, 2025 | Milestone Pharmaceuticals Inc. | $MIST | Muller Lorenz | Chief Commercial Officer | A | Common Shares | 66666 | $0.00 | 175,052.0000 | 53,464,273 | 61.51% | 0.12% |
| July 11, 2025 | Milestone Pharmaceuticals Inc. | $MIST | Muller Lorenz | Chief Commercial Officer | A | Series A Common Warrants (right to buy) | 66666 | $0.00 | 66,666.0000 | 53,464,273 | 9999.99% | 0.12% |
| July 11, 2025 | Milestone Pharmaceuticals Inc. | $MIST | Muller Lorenz | Chief Commercial Officer | A | Series B Common Warrants (right to buy) | 66666 | $0.00 | 66,666.0000 | 53,464,273 | 9999.99% | 0.12% |
| Jan. 27, 2025 | Milestone Pharmaceuticals Inc. | $MIST | Muller Lorenz | Chief Commercial Officer | A | Employee Stock Option (right to buy) | 120600 | $0.00 | 120,600.0000 | 53,327,908 | 9999.99% | 0.23% |
| Jan. 27, 2025 | Milestone Pharmaceuticals Inc. | $MIST | Muller Lorenz | Chief Commercial Officer | A | Restricted Stock Unit | 80400 | $0.00 | 80,400.0000 | 53,327,908 | 9999.99% | 0.15% |
| Feb. 16, 2023 | Milestone Pharmaceuticals Inc. | $MIST | Muller Lorenz | Chief Commercial Officer | A | Employee Stock Option (right to buy) | 105000 | $0.00 | 105,000.0000 | 34,286,002 | 9999.99% | 0.31% |